Dysregulated expression of IGSF11-AS1 and BVES-AS in azoospermia and its correlation with serum hormone levels.
Mohammed Ismael Ibrahim JeburNashwah Jabbar Kadhim MuttwaqiAzeez Hasan Saleh SalehReza SafaralizadehPublished in: Biomarkers in medicine (2024)
Aim: Azoospermia accounts for 10-20% of male infertility. In 20-30% of affected males, genetic abnormalities are the leading cause of azoospermia. LncRNAs can regulate spermatogenic cell development. Methods: This study chose 76 azoospermia patients and 36 healthy males. The gene expression was examined using the qRT-PCR technique. Results: IGSF11-AS1 and BVES-AS appeared to be considerably underexpressed in the patients; however, only IGSF11-AS1 demonstrated a significant biomarker role. Additionally, IGSF11-AS1 expression was positively correlated with testosterone but was negatively correlated with follicle-stimulating hormone (FSH) and luteinizing hormone (LH). For the BVES-AS gene, however, FSH and LH had a negative correlation. Conclusion: As a result of its low expression level in tissue samples, IGSF11-AS1 has a biomarker role for early azoospermia detection.
Keyphrases
- end stage renal disease
- gene expression
- poor prognosis
- newly diagnosed
- chronic kidney disease
- ejection fraction
- prognostic factors
- peritoneal dialysis
- dna methylation
- type diabetes
- stem cells
- cell therapy
- patient reported outcomes
- adipose tissue
- long non coding rna
- insulin resistance
- patient reported
- quantum dots
- sensitive detection